IMT Analytics AG has launched alveo, an advanced, high-fidelity lung simulator explicitly designed for device manufacturers, simulation centers, healthcare professionals, and research institutions.
With its state-of-the-art physiological modeling, alveo delivers exceptional accuracy in replicating realistic lung behavior, according to the company.
For Manufacturers: Enhance Device Innovation
alveo is a critical tool for developing, validating, and verifying medical devices. Its unmatched feature set allows manufacturers to simulate real-world conditions, accelerating the development and improvement of cutting-edge respiratory technologies.
For Healthcare Professionals: Revolutionize Training
Equipped with an in-built physiology model, alveo provides medical teams with an authentic training experience. From sharpening diagnostic skills to practicing advanced treatment techniques, the simulator ensures that healthcare professionals are better prepared for real-world challenges.
For Research Facilities: Explore New Frontiers
alveo is designed with researchers in mind. It offers capabilities to explore complex lung simulation scenarios with unparalleled depth. Its realistic lung behavior model provides a robust foundation for breakthrough studies and innovative medical solutions.
“alveo represents a paradigm shift in how to train and innovate in lung simulation,” said Harri Friberg, owner of IMT Analytics AG. “Its ability to replicate lung function with accuracy and high fidelity opens new possibilities for training, research, and device development. This tool can potentially improve patient outcomes through improved simulation training, advance scientific knowledge, and accelerate innovation in respiratory care.” alveo’s intuitive design ensures seamless integration into existing workflows, making it an accessible yet transformative solution for professionals across industries.
The new lung simulator from IMT Analytics AG will be available in Q3 2025. More information is available at the company’s website.
